Supplier Type
- Manufacturer
- Trader
- contract manufacturer
- Reagent
- custom synthesis
Supplier Region
- Hyderabad(27)
- Bangalore(2)
- Gujarat(45)
- Maharashtra(31)
- Mumbai(66)
- Delhi(10)
- Vadodara(9)
- Madhya Pradesh(1)
- Andhra Pradesh(1)
- Beijing(5)
- New Delhi(8)
- Ahmedabad(11)
- Pune(6)
- Karnataka(3)
- Haryana(3)
- Telangana(2)
- Nagpur(2)
- Uttar Pradesh(2)
- Tamil Nadu(4)
- Kolkata(1)
- Rajasthan(2)
- Punjab(1)
Purity
- yes
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Cotent of Cu +2 Min. 29%
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.56%
- 99.5%
- 99.5 %
- 99.42%
- 99.29%
- 99.23%
- 99.12%
- 99.08%
- 99.0%
- 99% Min
- >99%
- > 99%
- 99%
- 99 %
- 98+
- 98.65%
- 98.62%
- 98.60%
- 98.12%
- 98.00%
- 98% min
- >98%
- 98%
- 98 to 101%
- 98 - 99 %
- 97-99%
- 97.81%
- 97.57%
- 97%
- >97%
- 97 %
- 96.80%
- 96.39%
- 96% +
- 96% - 104%
- 96%
- 95.16%
- 95.10%
- 95.00%
- >95%
- 95%
- 94.34%
- 94.00%
- 94%
- >92%
- 90%
- >90%
- 90 % Above
- 28%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100% Pure
- 100
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1and gm
- 1MT
- 95NLT %
- 250250 mg.
-
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED
911661-90-0
-
Levothyroxine Impurity 29
2055-94-9
-
Levothyroxine T4 carboxamide impurity
-
β-Hydroxy Thyroxine
107849-54-7
-
Vibegron Impurity 29 -
Levothyroxine Impurity 16
909279-46-5
-
Levothyroxine Related Compound (2-Acetamido-3-(4-acetoxy-3,5-diiodophenyl)propanoic Acid)
153324-21-1
-
N-Acetyl-L-thyroxine Ethyl Ester
30804-52-5
-
LEVOTHYROXINE-LACTOSE MAILLARELATED COMPOUND IMPURITY -
Benzeneethanamine, 4-(3,5-diiodo-4-methoxyphenoxy)-3,5-diiodo-
2230724-39-5
Citric acid monohydrate 5949-29-1
2-Aminopyridine 504-29-0
Sodium tripolyphosphate 7758-29-4
Sodium tripolyphosphate 7758-29-4
(1S,2R)-(+)-Norephedrine hydrochloride 40626-29-7
Imipenem/cilastatin 92309-29-0
Potassium formate 590-29-4
Iron(II) ethylenediammonium sulfate tetrahydrate 34962-29-3
Citronella oil 8000-29-1
N-(Hydroxymethyl)-phthalimide 118-29-6